Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
The Journal of Biological Chemistry|May 23, 2012
The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanomaYoujun Chen, Cecile Chalouni, Christine Tan, et al.Cancer Research|February 12, 2004
EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancerWeiguang Mao, Elizabeth Luis, Sarajane Ross, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2015
Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian CancersKedan Lin, Bonnee Rubinfeld, Crystal Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
EphB2 is a prognostic factor in colorectal cancerAdrian M Jubb, Fiona Zhong, Sheila Bheddah, et al.The Journal of Pathology|April 1, 2009
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinomaLaura A Strickland, Jed Ross, Simon Williams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2015
A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCsShang-Fan Yu, Bing Zheng, MaryAnn Go, et al.Cancer Research|May 19, 2007
Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor modelsYoujun Chen, Suzanna Clark, Terence Wong, et al.Bioinformatics (Oxford, England)|April 10, 2004
GEPIS--quantitative gene expression profiling in normal and cancer tissuesYan Zhang, David A Eberhard, Gretchen D Frantz, et al.The Journal of Biological Chemistry|February 8, 2002
Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profilingDavid A Tice, Wayne Szeto, Irina Soloviev, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2012
Differential effects of predosing on tumor and tissue uptake of an 111In-labeled anti-TENB2 antibody-drug conjugateC Andrew Boswell, Eduardo E Mundo, Crystal Zhang, et al.Pageof 6